Philip Maes

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo et al. · The Lancet Haematology · 2019 · 315 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +13

Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease

James F. Casella, Bruce Barton, Julie Kanter et al. · JAMA · 2021 · 41 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Prolonged <i>versus</i> standard native <i>E. coli</i> asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951

Veerle Mondelaers, Stefan Suciu, Barbara De Moerloose et al. · Haematologica · 2017 · 31 citations · Full text

Medicine, Oncology, Pediatrics +15

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG

Jutte van der Werff ten Bosch, Stefan Suciu, A. Thyss et al. · Leukemia · 2005 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17

EFFECTIVENESS OF EARLY INITIATION OF PROTEASE INHIBITOR-SPARING ANTIRETROVIRAL REGIMEN IN HUMAN IMMUNODEFICIENCY VIRUS-1 VERTICALLY INFECTED INFANTS

Dimitri Van der Linden, Marc Hainaut, Tessa Goetghebuer et al. · The Pediatric Infectious Disease Journal · 2007 · 22 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17